Stephanie R. Penney , Roland M. Jones , Treena Wilkie , Cory Gerritsen , Sumeeta Chatterjee , Gary A. Chaimowitz , Alexander I.F. Simpson
{"title":"大麻合法化带来的临床和公共安全风险以及法医精神病患者使用大麻的频率。","authors":"Stephanie R. Penney , Roland M. Jones , Treena Wilkie , Cory Gerritsen , Sumeeta Chatterjee , Gary A. Chaimowitz , Alexander I.F. Simpson","doi":"10.1016/j.drugpo.2024.104622","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>There are ongoing concerns regarding the impact of Canada's cannabis legalization and commercialization on vulnerable persons such as those with serious forms of mental illness, including persons with schizophrenia-spectrum disorders and users of forensic mental health services. The primary objective of this study was to investigate the potential harms and mental health-related impacts associated with cannabis legalization on a sample of forensic patients in Ontario (<em>N</em> = 187).</div></div><div><h3>Methods</h3><div>Using a pseudo-prospective design, we investigated the frequency of cannabis use over a four-year period encompassing two years preceding and two years following the legislative change. We recorded clinical and public safety outcomes (i.e., mental health deterioration, length of stay in the forensic system, rates of hospital readmission, victimization and violence) over the same period to test relationships between these variables and rates of cannabis use.</div></div><div><h3>Results</h3><div>We found that one-third of patients either self-reported or were discovered, via urine testing, to have used cannabis over the study period. Frequency of use was lower in the pre-legalization period, and then gradually and significantly increased after legalization. Compared to patients with no cannabis use, those with one or more instances of use were more likely to be readmitted to hospital and had higher rated static risk factors for violence. However, there were no observed differences in the actual rate of violence between patients using and not using cannabis, nor differences in the rate of violence over time. Over half of the patients who used cannabis experienced a worsening of their mental health status in the week following use.</div></div><div><h3>Conclusions</h3><div>Cannabis use among those with SMI is associated with adverse clinical outcomes. Results from this study suggest that the mental health burdens associated with cannabis use have risen in terms of delayed clinical recovery and progress through the forensic system since legalization.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"134 ","pages":"Article 104622"},"PeriodicalIF":4.4000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical and public safety risks associated with cannabis legalization and frequency of cannabis use among forensic mental health patients\",\"authors\":\"Stephanie R. Penney , Roland M. Jones , Treena Wilkie , Cory Gerritsen , Sumeeta Chatterjee , Gary A. Chaimowitz , Alexander I.F. Simpson\",\"doi\":\"10.1016/j.drugpo.2024.104622\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>There are ongoing concerns regarding the impact of Canada's cannabis legalization and commercialization on vulnerable persons such as those with serious forms of mental illness, including persons with schizophrenia-spectrum disorders and users of forensic mental health services. The primary objective of this study was to investigate the potential harms and mental health-related impacts associated with cannabis legalization on a sample of forensic patients in Ontario (<em>N</em> = 187).</div></div><div><h3>Methods</h3><div>Using a pseudo-prospective design, we investigated the frequency of cannabis use over a four-year period encompassing two years preceding and two years following the legislative change. We recorded clinical and public safety outcomes (i.e., mental health deterioration, length of stay in the forensic system, rates of hospital readmission, victimization and violence) over the same period to test relationships between these variables and rates of cannabis use.</div></div><div><h3>Results</h3><div>We found that one-third of patients either self-reported or were discovered, via urine testing, to have used cannabis over the study period. Frequency of use was lower in the pre-legalization period, and then gradually and significantly increased after legalization. Compared to patients with no cannabis use, those with one or more instances of use were more likely to be readmitted to hospital and had higher rated static risk factors for violence. However, there were no observed differences in the actual rate of violence between patients using and not using cannabis, nor differences in the rate of violence over time. Over half of the patients who used cannabis experienced a worsening of their mental health status in the week following use.</div></div><div><h3>Conclusions</h3><div>Cannabis use among those with SMI is associated with adverse clinical outcomes. Results from this study suggest that the mental health burdens associated with cannabis use have risen in terms of delayed clinical recovery and progress through the forensic system since legalization.</div></div>\",\"PeriodicalId\":48364,\"journal\":{\"name\":\"International Journal of Drug Policy\",\"volume\":\"134 \",\"pages\":\"Article 104622\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2024-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Drug Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0955395924003062\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395924003062","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
Clinical and public safety risks associated with cannabis legalization and frequency of cannabis use among forensic mental health patients
Background
There are ongoing concerns regarding the impact of Canada's cannabis legalization and commercialization on vulnerable persons such as those with serious forms of mental illness, including persons with schizophrenia-spectrum disorders and users of forensic mental health services. The primary objective of this study was to investigate the potential harms and mental health-related impacts associated with cannabis legalization on a sample of forensic patients in Ontario (N = 187).
Methods
Using a pseudo-prospective design, we investigated the frequency of cannabis use over a four-year period encompassing two years preceding and two years following the legislative change. We recorded clinical and public safety outcomes (i.e., mental health deterioration, length of stay in the forensic system, rates of hospital readmission, victimization and violence) over the same period to test relationships between these variables and rates of cannabis use.
Results
We found that one-third of patients either self-reported or were discovered, via urine testing, to have used cannabis over the study period. Frequency of use was lower in the pre-legalization period, and then gradually and significantly increased after legalization. Compared to patients with no cannabis use, those with one or more instances of use were more likely to be readmitted to hospital and had higher rated static risk factors for violence. However, there were no observed differences in the actual rate of violence between patients using and not using cannabis, nor differences in the rate of violence over time. Over half of the patients who used cannabis experienced a worsening of their mental health status in the week following use.
Conclusions
Cannabis use among those with SMI is associated with adverse clinical outcomes. Results from this study suggest that the mental health burdens associated with cannabis use have risen in terms of delayed clinical recovery and progress through the forensic system since legalization.
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.